Liquid chromatography time-of-flight mass spectrometry (LC-MS/TOF) coupled with specialized trial tags—such as tag 140—provides researchers with unprecedented accuracy in peptide identification, structural elucidation, and quantitative purity profiling. PX1 Research delivers analytical-grade compounds subjected to high-resolution mass spectrometry and lot-specific verification to support rigorous laboratory workflows.
Liquid chromatography time-of-flight mass spectrometry (LC-MS/TOF) coupled with specialized trial tags—such as tag 140—provides researchers with unprecedented accuracy in peptide identification, structural elucidation, and quantitative purity profiling. PX1 Research delivers analytical-grade compounds subjected to high-resolution mass spectrometry and lot-specific verification to support rigorous laboratory workflows.
In modern analytical biochemistry and proteomic workflows, liquid chromatography time-of-flight mass spectrometry (LC-MS/TOF) paired with chemical trial tags—specifically mass tag 140—represents a precision standard for quantitative peptide characterization. Trial tags are isobaric or mass-differential chemical labels designed to covalently bind to specific functional groups, such as primary amines at the N-terminus or lysine residues, enabling accurate mass identification and multiplexed comparative profiling under high-resolution mass spectrometry.
The designation LC-MS/TOF trial tags 140 refers to a distinct reporter tag channel or fragmentation tag generating a characteristic signature ion at m/z 140 during tandem mass spectrometry collision-induced dissociation (CID) or higher-energy collisional dissociation (HCD). For investigators conducting peptide purity testing methods, integrating LC-MS/TOF with tag 140 facilitates exact mass determination, sequence alignment verification, and precise quantification of target analytes alongside potential trace side-products or synthesis truncated sequences.
Time-of-flight (TOF) mass analyzers operate by accelerating ionized peptide molecules through an electrostatic field into a field-free drift region. Because all ions receive identical kinetic energy during acceleration, their velocity—and consequently their flight time to the ion detector—is inversely proportional to the square root of their mass-to-charge ratio (m/z). High-resolution TOF instruments achieve mass accuracies under 5 parts per million (ppm), allowing laboratory researchers to resolve minute mass discrepancies that distinguish full-length peptides from minor impurities.
When combined with liquid chromatography (LC), high-performance separation occurs prior to electrospray ionization (ESI). Reverse-phase HPLC channels separate peptide species based on hydrophobic interaction, while the TOF detector captures real-time high-resolution mass spectra. For complex research workflows involving mass spectrometry peptide analysis, this dual-dimensional separation ensures that isobaric mass tags—such as trial tag 140—can be measured with high mass resolution, eliminating background chemical interference.
Isobaric mass tagging protocols rely on tripartite molecular tag designs: a reactive functional head group (e.g., N-hydroxysuccinimide ester), a balance group, and a reporter group. In the case of trial tag 140, the reporter group dissociates during MS/MS fragmentation to produce a stable fragment ion centered precisely at 140.1 m/z. In vitro chemical assays demonstrate that reaction stoichiometry, pH buffers, and organic co-solvent concentrations govern tagging efficiency.
Preclinical and in vitro studies indicate that amine-reactive trial tags undergo nucleophilic substitution with primary amines on peptide backbones with yields exceeding 98% under optimized alkaline conditions (pH 8.0–8.5). By utilizing trial tag 140 in quantitative assays, investigators can evaluate comparative peptide degradation rates, receptor binding affinity samples, and stability kinetics across varied experimental conditions, relying on the predictable fragmentation signature of tag 140.
Achieving optimal peak separation in LC-MS/TOF workflows requiring trial tags 140 necessitates precise mobile phase optimization. Standard setups employ C18 or C8 reverse-phase stationary phase columns with a linear gradient of water and acetonitrile supplemented with 0.1% formic acid or 0.05% trifluoroacetic acid (TFA) as ion-pairing agents. Formic acid is often preferred in ESI-TOF applications to prevent ion suppression while maintaining sharp chromatographic peak shapes.
Column temperature, flow rates (typically 0.2 to 0.4 mL/min for microbore columns), and gradient slopes are adjusted to resolve tagged target analytes from unreacted chemical tags or synthesis truncations. Advanced protocols detail how adjusting elution parameters improves signal-to-noise ratios for the 140 m/z reporter ion, ensuring robust quantitative metrics when evaluating sample integrity in the PX1 Research analytical hub.
In vitro research applications of LC-MS/TOF trial tag 140 span diverse domains of peptide biochemistry, including stoichiometry verification, translational post-translational modification (PTM) mapping, and comparative pharmacokinetic modeling in animal models. By tagging reference samples alongside experimental fractions, researchers establish internal standards that normalize instrument drift across long analytical sequences.
Data from preclinical literature show that trial tag 140 labeling protocols enable reliable quantification of peptide oxidation, deamidation, and aggregation kinetics. Whether evaluating synthetic signaling peptides or novel therapeutic candidates in preclinical cell culture systems, high-resolution LC-MS/TOF analysis tagged at 140 m/z delivers the quantitative accuracy required for high-impact laboratory research.
Evaluating research compounds requires selecting the appropriate analytical framework depending on research objectives. Native synthetic peptides offer direct physiological relevance in cell-culture or receptor-binding assays, whereas tagged compounds excel in quantitative structural mass spectrometry. Below is a comparative overview of standard research peptides vs. chemical trial tag workflows:
For instance, when evaluating metabolic signaling peptides such as Semaglutide compound, custom trial tagging allows tracking of degradation metabolites in vitro. Similarly, tissue regeneration peptides such as BPC-157 research peptide and TB-500 synthetic peptide can be analyzed via LC-MS/TOF to confirm primary amino acid sequencing, post-synthesis purity, and batch-to-batch consistency across experimental trials.
Rigorous laboratory investigation demands high analytical standards for raw peptide reagents. Impurities in synthetic compounds—such as sequence deletion sequences, residual heavy metals, or bacterial endotoxins—can compromise in vitro cell culture viability and skew MS spectral data. PX1 Research mandates third-party laboratory verification for every single lot produced.
Every research compound supplied by PX1 Research undergoes rigorous testing in ISO 17025 accredited facilities, utilizing both reverse-phase HPLC for purity percentage (>99% purity benchmark) and high-resolution ESI-TOF mass spectrometry for absolute molecular weight confirmation. Furthermore, compounds undergo Chromogenic Limulus Amebocyte Lysate (LAL) testing to confirm endotoxin levels fall below strict laboratory safety thresholds (<0.01 EU/mg), ensuring reliable results for preclinical studies.
Proper handling and storage of research compounds and chemical trial tags are critical to prevent hydrolytic degradation, oxidative modification, or non-specific adsorption to plastic container walls. Synthetic peptides supplied as lyophilized powders should be stored at -20°C or -80°C in desiccated chambers away from light exposure.
When reconstituting peptides for LC-MS/TOF analysis or trial tag labeling, researchers should use sterile, degassed LC-MS grade solvents, such as ultrapure water or 0.1% formic acid in water/acetonitrile mixtures. Avoid repeated freeze-thaw cycles by aliquoting reconstituted solutions into low-binding polypropylene microcentrifuge tubes. For high-volume research institutions, sourcing reagents through the PX1 Research wholesale platform provides bulk access to fully verified, high-purity compounds.
Selecting a reliable supplier for research-grade peptides and mass spectrometry reagents requires evaluating key quality indicators. Research institutions should prioritize suppliers operating GMP-compliant manufacturing facilities in the United States, providing lot-traceable documentation and publicly accessible certificate of analysis (COA) records.
PX1 Research maintains complete domestic production standards, shipping directly from facilities in California and Arizona with same-day fulfillment (Monday–Friday). By enforcing strict quality control protocols—including LC-MS/TOF structural validation and low-endotoxin thresholds—PX1 Research ensures that analytical researchers receive pure, reproducible materials designed strictly for in vitro laboratory research.
What is the primary function of LC-MS/TOF trial tag 140 in peptide research?
LC-MS/TOF trial tag 140 serves as a high-resolution isobaric or mass-differential chemical label used in quantitative mass spectrometry. It attaches to primary amines on peptides, producing a characteristic 140 m/z reporter ion during collision-induced dissociation for precise quantification and structural identification.
How does TOF mass spectrometry differ from Orbitrap or quadrupole mass analyzers?
Time-of-flight (TOF) mass spectrometry measures the time taken for ions to travel down a field-free flight tube, offering rapid spectrum acquisition speeds, wide mass ranges, and high mass resolution (<5 ppm). quadrupole analyzers select specific m/z windows, while Orbitrap instruments utilize electrostatic trapping for extreme resolution.
Are PX1 Research compounds suitable for human clinical administration?
No. All products supplied by PX1 Research are strictly designated for laboratory research use only, including in vitro assays and preclinical animal models. They are not intended for human or animal consumption, medical treatment, diagnosis, or clinical use.
What documentation is provided to verify peptide purity?
Every lot supplied by PX1 Research includes a lot-specific Certificate of Analysis (COA) featuring reverse-phase HPLC purity chromatograms (>99% purity), ESI-TOF mass spectra for structural validation, and endotoxin assay reports (<0.01 EU/mg).
How should trial tag 140 labeled samples be stored for LC-MS analysis?
Labeled peptide samples should be stored at -80°C in low-binding microcentrifuge tubes under anhydrous conditions to prevent hydrolysis. Reconstituted LC-MS samples should be analyzed within 24–48 hours or kept in temperature-controlled autosamplers at 4°C.
What solvent system is recommended for LC-MS/TOF peptide analysis?
A standard gradient system consists of Mobile Phase A (0.1% formic acid in LC-MS grade water) and Mobile Phase B (0.1% formic acid in LC-MS grade acetonitrile) utilizing a C18 reverse-phase column.
Where are PX1 Research compounds manufactured and shipped from?
PX1 Research compounds are manufactured in domestic, GMP-compliant facilities within the USA and shipped directly from fulfillment centers in California and Arizona with same-day shipping on weekday orders.
Can chemical trial tags be used for post-translational modification (PTM) analysis?
Yes. Isobaric trial tags like tag 140 allow quantitative comparison of modified vs. unmodified peptides, facilitating mapping of phosphorylation, acetylation, or oxidation states in preclinical research.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.